Study #2016-0687
Haloperidol and/or Chlorpromazine for Refractory Agitated Delirium in the Palliative Care Unit
MD Anderson Study Status
Not Accepting
Treatment Agent
Haloperidol, Chlorpromazine
Description
This randomized phase II/III trial studies how well haloperidol with or without chlorpromazine works in treating delirium in patients with cancer that has spread to other parts of the body or has come back. Haloperidol and chlorpromazine may control the symptoms of delirium (loss of contact with reality) in patients with cancer.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Advanced Malignant Neoplasm, Delirium, Locally Advanced Malignant Neoplasm, Metastatic Malignant Neoplasm, Recurrent Malignant Neoplasm
Study phase:
Phase II/III
Physician name:
David Hui
Department:
Palliative Care & Rehabilitation Medicine
For general questions about clinical trials:
1-855-625-0962
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.